<DOC>
	<DOCNO>NCT02458261</DOCNO>
	<brief_summary>This prospective , multi-center study aim determine pharmacokinetics pharmacodynamics extended-infusion cefepime continuous renal replacement therapy ( CRRT ) .</brief_summary>
	<brief_title>Pharmacokinetics Pharmacodynamics Extended-Infusion Cefepime Continuous Renal Replacement Therapy</brief_title>
	<detailed_description>This prospective , multi-center study aim determine pharmacokinetics pharmacodynamics extended-infusion cefepime CRRT . Patients CRRT initiate cefepime 2000 mg IV every eight hour four-hour infusion consider enrollment . Pre- post-membrane serum level draw schedule interval first dose another dose steady state . Concomitant effluent urine level also obtain . A pharmacokinetic analysis perform Monte Carlo simulation use determine probability target attainment various pharmacodynamic endpoint . Documented organism MICs use determine cumulative fraction response .</detailed_description>
	<mesh_term>Cefepime</mesh_term>
	<criteria>Age â‰¥ 18 year Admission medical intensive care unit ( MICU ) , surgical intensive care unit ( SICU ) , neuroscience intensive care unit ( NSICU ) , cardiovascular intensive care unit ( CVICU ) , University Cincinnati Medical Center , mixed ICU West Chester Hospital Patients receive continuous venovenous hemofiltration continuous venovenous hemodialysis Receiving empiric definitive cefepime 2 g IV every 8 hour fourhour infusion Prisoners Pregnant woman Patients cystic fibrosis Burns patient 24hour urine output &gt; 400 mL unknown</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>